Gas chromatography tandem mass spectrometry offers advantages for urinary steroids analysis by Homer, Natalie et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gas chromatography tandem mass spectrometry offers
advantages for urinary steroids analysis
Citation for published version:
Homer, N, Kothiya, S, Rutter, A, Walker, B & Andrew, R 2017, 'Gas chromatography tandem mass
spectrometry offers advantages for urinary steroids analysis' Analytical Biochemistry, vol. 538. DOI:
10.1016/j.ab.2017.09.002
Digital Object Identifier (DOI):
10.1016/j.ab.2017.09.002
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Analytical Biochemistry
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
 1
 GAS CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OFFERS ADVANTAGES FOR URINARY 
STEROIDS ANALYSIS 
 
NATALIE HOMERa, SANJAY KOTHIYAb, ALISON RUTTERb, BRIAN R WALKERb, RUTH ANDREWb 
 
 
 
a Edinburgh Clinical Research Facility Mass Spectrometry Core, Queen’s Medical Research 
Institute, University of Edinburgh, 47, Little France Crescent, Edinburgh, EH16 2TJ, UK 
b University/ British Heart Foundation Centre for Cardiovascular Science, Queen’s Medical 
Research Institute, University of Edinburgh, 47, Little France Crescent, Edinburgh, EH16 2TJ, 
UK 
Email addresses: n.z.n.homer@ed.ac.uk, kothiyasanjay@gmail.com, a.ayres@ed.ac.uk, 
b.walker@ed.ac.uk, ruth.andrew@ed.ac.uk 
Author for Correspondence: Ruth Andrew 
Running Title: Analysis of urinary steroids by tandem mass spectrometry 
Subject Category: Mass Spectrometry 
 
 
 
 2
ABSTRACT  
 
Gas chromatography mass spectrometry has been the lynchpin of clinical assessment of 
steroid profiles for ~3 decades. The improvements in assay performance offered by tandem 
mass spectrometry were assessed. Across the spectrum of glucocorticoid and androgen 
analytes tested, limits of detection and quantitation were ~20 fold lower with triple than single 
quadrupole systems, but the more noticeable improvement was that signal to noise was 
substantially improved and the linear range wider. These benefits allowed more reliable and 
concomitant measurement of steroids with substantially different abundances and in smaller 
volumes of urine. 
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INTRODUCTORY STATEMENT 
 
Profiling of urinary metabolites of adrenal and gonadal steroids has been performed routinely 
for approximately 30 years, with several seminal papers by Shackleton et al (1, 2) defining an 
approach that is used worldwide in research and clinical diagnosis, also being extended to the 
fields of toxicology and doping. Clinically, such analysis has been used widely in the 
diagnosis of inborn errors of metabolism and more recently in the differential diagnosis of 
adrenal tumours (3). Originally a profile of steroids measured as their methoxyamine-
trimethylsilyl derivatives was performed by gas chromatography (GC) with electrochemical 
detection (ECD), but more recently steroids have been identified by single quadrupole mass 
spectrometers (MS). The use of MS enhances specificity over ECD, but challenges remain. 
The amounts of steroids and their metabolites differ greatly both between analytes and disease 
states, meaning calibration ranges can differ substantially. In particular some steroids are 
present in low abundance (e.g. cortisol and cortisone) and close to the acceptable limits for 
quantitation (LOQs), even following extraction of relatively large volumes (~20 mL) of urine. 
 
Signal to noise can be improved using tandem MS (MS/MS), lowering the LOQs. Recently 
there has been a move towards liquid chromatography (LC)-MS/MS as the method of choice 
for quantitative analysis. Higher throughput can be achieved as derivatisation is not routinely 
required. Despite poor ionisation efficiency, some neutral steroids can be successfully 
quantified by electrospray (ESI) and atmospheric pressure chemical (APCI) ionisation, 
although their signal is susceptible to ion suppression by the matrix. Nonetheless the more 
abundant circulating pregnene and androstene steroids, such as cortisol and testosterone, are 
now routinely quantified by this means (4). However their metabolic products, some of which 
retain biological activity (5), cannot be detected nor discriminated readily using LC-MS/MS. 
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Metabolism of the keto-enol function in the A-ring forms 5 and 5-reduced dihydro 
products, followed by subsequent reduction of the 3-keto by 3 and -hydroxysteroid 
dehydrogenases (6) and yields metabolites that ionise poorly. Moreover separation of multiple 
sets of stereo-isomers is problematic by LC. 
 
GC-MS/MS therefore holds inherent advantages for steroid hormones as they present a 
portfolio of lipophilic analytes with close structural similarity. The isomeric derivatives 
formed for GC analysis can be resolved more readily, facilitating stereochemical 
discrimination and the intensity of the signal from the derivatives of the metabolites is not 
compromised compared to the precursor hormone. We have adapted the GC-based approach 
of urinary steroid analysis by single quadrupole analysis to exploit the power of tandem mass 
spectrometry and report here the validated assay. 
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MATERIALS AND METHODS 
 
Instrumentation 
Analysis was performed on a Trace GC Ultra, equipped with a DB17MS column (30 m, 0.25 
mm, 0.25 µm, Agilent Technologies Ltd., Stockport, UK), fitted with a AS autosampler and 
interfaced with a TSQ Quantum triple quadrupole MS (Thermoscientific, Hemel Hempstead, 
UK). Data were processed using Xcalibur Software version 3.0. Samples (1 μL) were injected 
(120°C) using a Programmed Temperature Vaporising injector, with a constant helium flow 
of 1.5 mL/minute. The injector temperature increased to 270°C at 14.5°C/minute, held for 1 
minute and then increased at the same rate to 300°C, held for 10 minutes and returned to 
baseline. The initial GC temperature was 120°C and increased (30°C/minute) to 200°C, then 
after 1 minute increased (5°C/minute) to 300°C and sustained for 5 minutes. The auxiliary 
line and source temperatures were 280 °C. The MS was operated in electron impact (70 eV), 
using argon as a collision gas, at a pressure of 1 mTorr.  
Sources of chemicals 
Unlabelled steroids (Table 1) and internal standards were from Steraloids (Rhode Island, 
USA). Other chemicals were from Sigma-Aldrich (Poole, UK) unless otherwise stated. 
Lipidex-5000 was from Perkin-Elmer (Cambridge, UK). Solvents were glass-distilled HPLC 
grade (Fisher Scientific, Loughborough, UK). Trivial and systematic names of steroid 
metabolites are 5β-tetrahydrocortisol (5βTHF), 3α,11β,17α,21-tetrahydroxy-5β-pregnan-20-
one; 5α-tetrahydrocortisol (5αTHF), 3α,11β,17α,21-tetrahydroxy-5α-pregnan-20-one; 
tetrahydrocortisone (THE), 3α,17α-21-trihydroxy-5β-pregnan-11,20-dione; α-cortol, 5β-
pregnane-3α,11β,17,20α,21-pentol; β-cortol, 5β-pregnane-3α,11β,17,20β,21-pentol, α-
cortolone, 3α,17α,20α,21-tetrahydroxy-5β-pregnan-11-one; β-cortolone, 3α,17α,20β,21-
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tetrahydroxy-5β-pregnan-11-one; etiocholanolone, 5β-androstan-3α-ol-17-one; androsterone, 
5α-androstan-3α-ol-17-one. 
Derivatisation of Steroids or Extracts 
Steroids were dissolved in methanol (1 mg/mL) and stored at -20oC. Serial methanolic 
dilutions were performed and aliquots of standards or whole extracts reduced to dryness under 
oxygen-free nitrogen (60oC) in Reacti Vials. Methoxime-trimethylsilyl derivatives were 
formed (7) and dissolved in decane (200 μL) and 1 μL injected. 
MS parameters 
Full scans of derivatised standards were performed in Q1 (100 ng/200 μL). Potential 
precursor ions were subject to collision (increments of 5 between 0-40 V), and product ion 
scans collated. Four suitable transitions were initially selected for dynamic selected reaction 
monitoring (SRM) and the two yielding the most intense signals for standards and 
subsequently best signal to noise in representative biological samples selected as quantifier 
and qualifier ions (Table 1). Time windows of 3 minutes were typical. Steroids co-eluting (e.g. 
analyte and stable-isotope labelled internal standard) were examined separately to ensure lack 
of interference between ion transitions. 
Extraction of urinary steroids 
Steroids were extracted from aliquots (1-20 mL) of 24 hour urine collected from healthy male 
subjects (8) with ethical approval and pooled into 6 replicates (n=6). Water was used as the 
matrix for calibration standards. 
Assay validation 
Limits of detection (LODs) of unextracted steroid standards were assigned as peaks with 
signal-to-noise of >3. Recovery of analytes was assessed from water by comparing signal 
intensity after extraction with matched unextracted standards. Calibration curves were 
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prepared with serial dilutions of analytes (lowest point LOD) and fixed quantities of internal 
standards (11-epi-cortisol (1.5 µg), 11-epi-tetrahydrocortisol (15 µg), androstandiol (5 µg). 
The following amounts were included in the calibration curves: 5βTHF, 5αTHF, THE (0.05, 
0.1, 0.5, 1, 2, 5*, 10, 20, 30, 40, 50, 100, 150, 200, 300# µg); androsterone, etiocholanolone, α 
and β-cortol, α and β-cortolone, cortisol and cortisone (0.025, 0.05, 0.25, 0.5, 1, 2.5*, 5, 10, 
15, 20, 25, 50, 75, 100, 150# µg). Linearity was assessed by least squared regression analysis 
and weightings (equal, 1/x and 1/x2) compared. The precision of replicate injections was 
assessed by reinjecting the same standard (low* being either 2.5 or 5 µg, high# being either 
150 or 300 µg) 6 times. In 6 replicates of standards of the amounts equivalent to the lower 
limit of quantitation and high amounts as above, accuracy (relative mean error; RME) and 
precision (% relative standard deviation; RSD) were assessed following extraction (intra- and 
inter-assay). The limits of quantitation (LOQs) were assigned where accuracy and precision 
achieved %RME and %RSD <20%. At other points, values <15% were deemed acceptable. 
(RME= (Amount measured-theoretical amount)/theoretical amount; RSD=Standard Deviation 
of replicates/Mean).  
 
Recovery of internal standards from urine was assessed by comparing results of samples 
spiked before and after extraction. The precision of replicate injections of urine (1 or 10 mL) 
was assessed by reinjecting the same sample 6 times. Replicates (n=6) of pooled urine sample 
were analysed on the same day and reanalysed after 12 m storage at -20 oC and precision of 
analysis assessed.  
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RESULTS AND DISCUSSION 
 
The existing method for single quadrupole analysis was adapted for triple quadrupole 
detection. Ions previously selected for single quadrupole analysis were uniformly present in 
the Q1 scans, and ultimately selected as the precursor ions for SRM. The transitions (Table 1) 
yielding the most intense products ions, with the greatest signal to noise ratios were selected 
and largely represented loss of derivative functions (m/z minus 90 or 31) as predicted from 
full scan spectra. Collision energies were selected to retain small amounts of precursor ion 
(<5% where possible). Raising the source temperature noticeably improved signal intensity 
(280 vs 200oC), possibly reflecting manufacturer-specific source design. Chromatographic 
conditions required adjustment potentially to accommodate interfacing with a PTV injection 
as opposed to split-splitless mode, PTV offering advantages with cleaner sample introduction. 
 
Linear Range of Quantitation 
Replicate injections of standards yielded peak areas recorded with RSDs of 1.1-11.8% (Table 
1). The LODs of unextracted standards was approximately 500 pg on column for all steroids. 
Broadly the LOQ was 10 fold higher than the LOD and this increment was most marked for 
cortols and cortolones, probably due to their poorer chemical similarity to the internal 
standard used. Quantitation was linear over a wider dynamic range than observed previously 
using single quadrupole analysis. Although not routinely required, 3 orders of magnitude 
dynamic range could be achieved, if higher concentration samples were diluted to volumes 
larger than 200 µL. Generally, a weighting of 1 yielded best fit lines and good fit of the low 
points was better achieved by limiting the range of the line to one order of magnitude, rather 
than by adjusting weighting. 
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Recovery of standards and internal standards from water was excellent and close to 100% 
(Table 1). Intra- and inter-assay precision and accuracy of extracted standards are in Tables 2.  
 
Application to Biological Samples 
Recovery of internal standards from urine samples was ~ 66-72% and the extraction process 
did not substantially influence the variability of recovery as seen by comparing RSD pre- or 
post-spiking the internal standard (Table 2). Replicate injections of urine samples yielded 
precise results, comparable to standards (Table 1). Precision was improved in urinary 
extraction by reducing the amount of sample per Sep-pak. Protocols have been reported that 
employ the use of the same cartridge for the initial extraction and the extraction post-
hydrolysis (2). This was acceptable when volumes of up to 10 mL were extracted but proved 
less reliable at larger volumes for 300 mg cartridges. Excellent precision was also sustained 
when volumes were scaled down to 1 mL with all analytes detectable, not previously 
achievable with single quadrupole systems. This has advantages in speed and cleanliness for 
instrument maintenance and is potentially scalable to a 96 well plate format. 
 
Signal to noise ratios of analytes in biological matrix measured by triple quadrupole MS were 
far superior to single quadrupole analysis. Exemplary mass chromatograms are shown in 
Table 1B with much reduced background noise. Intra-assay precision was excellent (Table 2). 
Subsequent re-injection of derivatised samples after storage at -20oC for 12 m showed that the 
signal for analytes was stable during this period, with declines in reported abundance of no 
greater than 20%. 
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CONCLUSIONS 
Triple quadrupole MS offers advantages over conventional single quadrupole analysis and 
advances the performance of urinary steroid profiling. The most notable improvements were 
in the signal to noise as well as the dynamic range. This was reflected in better performance 
of the urinary steroid assay in terms of precision and accuracy compared with our previous 
single quadrupole method. For higher abundance analytes analysis of volumes of 1 mL may 
be performed but there may still advantages to processing larger volumes to increase the 
scope of the metabolite profile or record quantities of unconjugated steroids. This approach 
will take its place among other MS techniques and may be compared by other contemporary 
approaches being explored at the GC interface such as convergence chromatography (9) 
which allows more rapid chromatography and higher throughput.  
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Table 1 
RSD= Relative Standard Deviation; RME= Relative Mean Error; LOD/Q = Limit of 
detection/quantitation; Qn = Quantifier; Ql = Qualifier; Tetrahydrocortisol =THF, 
Tetrahydrocortisone = THE.  
 
 
Table 1A 
Steroidal derivative Mass Transition (m/z) 
Precursor → Product 
Collision  
Energy  
Replicate Injections 
% RSD 
Aqueous 
Recovery 
Analytes Quantifier Qualifier Qn, Ql (V) Low High Urine % 
(5)-Androsterone 360270 360213 15,15 3.5 0.9 1.1 90.5 
(5)-Etiocholanolone 360270 360213 15,15 4.0 1.2 2.1 91.8 
5THF 652562 562472 15,20 1.1 1.9 4.4 111.6 
5THF 652562 562472 15,20 1.9 0.6 2.2 109.5 
THE 578398 578488 15,15 2.7 0.4 0.7 112.5 
-Cortol 535445 535355 15,20 2.4 1.8 5.3 96.4 
-Cortol 535445 535355 15,20 2.4 0.7 2.7 115.7 
-Cortolone 449269 449359 10,15 8.9 1.1 0.6 94.1 
-Cortolone 449269 449359 10,15 8.0 1.2 1.5 112.3 
Cortisol 605515 515425 20,15 11.8 2.1 4.1 104.9 
Cortisone 531441 441382 15,15 3.7 2.0 2.8 119.5 
Internal Standards  
11-Epi-Cortisol 605515 515425 20,15  94.4 
11-Epi-THF 652562 562472 15,20 97.2 
3,17 -Androstanediol 331241 331255 15,10 103.1 
Table 1B 
Mass chromatogram of derivatised cortisone analysed by (i) single quadrupole or (ii) triple quadrupole 
mass spectrometry following gas chromatographic separation 
 
Table 2: Lower and Upper Limits of Quantitation (LLOQ/ULOQ) of Steroids Pre-and Post-extraction 
 RSD= Relative Standard Deviation; RME= Relative Mean Error; IS = internal standard; L/ULOQ lower and upper limit of quantitation 
 
 LLOQ Standards Extracted (n=6) ULOQ Standards Extracted (n=6) Urine (n=6) 
  Intra-assay  Inter-assay   Intra-assay Inter-assay  Intra-assay Precision  
(%) 
%  
Original 
Steroids LLOQ 
ng on 
column 
%RSD  %RME %RSD  %RME ULOQ 
ng on 
column 
%RSD  %RME %RSD %RME IS 
Post-
spiked  
IS Pre- 
Spiked 
10 mL  
IS Pre- 
Spiked 
1 mL 
20 oC,  
12 m 
 
Androsterone 12.5 4.9 112.8 17.1 103.9 750 7.8 95.7 13.5 96.05 5.2 4.5 11.7 109.2 
Etiocholanolone 12.5 7.7 113.0 8.3 100.8 750 8.9 111.4 3.4 99.95 5.7 4.5 10.6 105.3 
5βTHF 25 13.5 95.7 7.9 102.7 1500 2.5 107.6 2.7 101.2 6.5 2.0 3.2 93.0 
5αTHF 25 7.5 94.7 12.9 107.7 1500 3.5 101.5 2.4 101.2 6.3 1.9 6.4 80.0 
THE 25 8.6 94.0 14.8 105.4 1500 4.2 88.7 1.9 101.7 6.5 1.6 0.9 100.8 
α-cortol 12.5 11.8 100.8 6.0 89.3 750 4.5 86.7 1.4 102.7 10.8 6.5 8.7 102.1 
β-cortol 12.5 12.9 105.4 20.2 86.3 750 3.5 98.8 2.8 101.8 5.4 7.5 6.4 109.8 
α-cortolone 12.5 15.5 113.4 20.6 90.7 750 3.1 99.4 4.9 100.5 8.5 3.0 5.4 115.2 
β-cortolone 12.5 13.4 106.2 12.8 106.0 750 2.7 99.1 2.6 99.6 8.0 6.4 5.8 97.2 
cortisol 2.5 6.2 102.6 10.3 95.0 150 2.4 99.5 1.8 100.5 6.3 4.3 7.5 109.2 
cortisone 2.5 14.0 100.2 12.2 102.7 150 2.8 99.6 1.0 101.6 7.1 3.4 3.9 105.3 
